Ratings by Wells Fargo (Nathan Treybeck)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/18/2026 | iRhythm Technologies | IRTC | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/7/2026 | iRhythm Technologies | IRTC | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/7/2026 | ResMed | RMD | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 8/5/2026 | LeMaitre Vascular | LMAT | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 8/5/2026 | Procept BioRobotics Corp | PRCT | Downgrade | Equal Weight (Overweight) |
18.28 (20.91) |
14.39% | Details | |
| 8/4/2026 | Integer Holding | ITGR | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 7/8/2026 | ResMed | RMD | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 5/1/2026 | iRhythm Technologies | IRTC | Maintain | Overweight (N/A) |
|
Details | ||
| 2/26/2026 | LeMaitre Vascular | LMAT | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 2/26/2026 | Procept BioRobotics Corp | PRCT | Maintain | Overweight (N/A) |
|
Details | ||
| 2/20/2026 | iRhythm Technologies | IRTC | Maintain | Overweight (N/A) |
|
Details | ||
| 2/20/2026 | Integer Holding | ITGR | Maintain | Equal Weight (N/A) |
|
Details | ||
| 1/13/2026 | iRhythm Technologies | IRTC | Maintain | Overweight (Overweight) |
|
Details | ||
| 12/12/2025 | Integer Holding | ITGR | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 12/12/2025 | LeMaitre Vascular | LMAT | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 11/5/2025 | Procept BioRobotics Corp | PRCT | Maintain | Overweight (N/A) |
|
Details | ||
| 10/31/2025 | iRhythm Technologies | IRTC | Maintain | Overweight (Overweight) |
|
Details | ||
| 10/24/2025 | Integer Holding | ITGR | Downgrade | Equal Weight (Overweight) |
109.11 (125.39) |
14.92% | Details | |
| 8/7/2025 | Procept BioRobotics Corp | PRCT | Maintain | Overweight (N/A) |
|
Details | ||
| 8/6/2025 | LeMaitre Vascular | LMAT | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 8/1/2025 | iRhythm Technologies | IRTC | Maintain | Overweight (Overweight) |
|
Details | ||
| 7/25/2025 | Integer Holding | ITGR | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/2/2025 | iRhythm Technologies | IRTC | Upgrade | Overweight (Equal Weight) |
108.59 (122.35) |
12.67% | Details | |
| 4/28/2025 | Procept BioRobotics Corp | PRCT | Maintain | Overweight (Overweight) |
|
Details | ||
| 4/28/2025 | Integer Holding | ITGR | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/21/2025 | iRhythm Technologies | IRTC | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 2/13/2025 | LeMaitre Vascular | LMAT | New Coverage | Equal Weight (N/A) |
96.32 (81.08) |
-15.82% | Details | |
| 12/11/2024 | Nevro Corp | NVRO | Maintain | Equal Weight (N/A) |
|
Details | ||
| 8/7/2024 | Nevro Corp | NVRO | Downgrade | Underweight (Equal Weight) |
8.69 (5.84) |
-32.8% | Details | |
| 8/2/2024 | Procept BioRobotics Corp | PRCT | Maintain | Overweight (N/A) |
|
Details | ||
| 5/20/2024 | iRhythm Technologies | IRTC | Maintain | Overweight (N/A) |
|
Details | ||
| 5/8/2024 | Nevro Corp | NVRO | Maintain | Equal Weight (N/A) |
|
Details | ||
| 4/26/2024 | Integer Holding | ITGR | Maintain | Equal Weight (N/A) |
|
Details | ||
| 4/8/2024 | Nevro Corp | NVRO | New Coverage | Equal Weight (N/A) |
13.29 (5.84) |
-56.06% | Details | |
| 2/28/2024 | Procept BioRobotics Corp | PRCT | Maintain | Overweight (N/A) |
|
Details | ||
| 1/11/2024 | Integer Holding | ITGR | Maintain | Equal Weight (N/A) |
|
Details | ||
| 1/9/2024 | Procept BioRobotics Corp | PRCT | Maintain | Overweight (N/A) |
|
Details | ||
| 12/13/2023 | Procept BioRobotics Corp | PRCT | Maintain | Overweight (N/A) |
|
Details | ||
| 7/28/2023 | Integer Holding | ITGR | Maintain | Equal Weight (N/A) |
|
Details | ||
| 5/26/2023 | Integer Holding | ITGR | New Coverage | Equal Weight (N/A) |
80.14 (125.39) |
56.46% | Details | |
| 4/28/2023 | Procept BioRobotics Corp | PRCT | Maintain | Overweight (N/A) |
|
Details | ||
| 1/12/2023 | Procept BioRobotics Corp | PRCT | Maintain | Overweight (N/A) |
|
Details | ||
| 12/12/2022 | Procept BioRobotics Corp | PRCT | Maintain | Overweight (N/A) |
|
Details | ||
| 9/2/2022 | Procept BioRobotics Corp | PRCT | New Coverage | Overweight (N/A) |
40.38 (18.28) |
-54.73% | Details |
